Results 201 to 210 of about 39,915 (240)
Urine analysis in monoclonal gammopathies at diagnosis: settling cut-off values. [PDF]
Vidal-Pla M+3 more
europepmc +1 more source
GLS1‐mediated glutaminolysis supports GSH synthesis in cancer cells. GLS1 KO increases ROS, downregulates GPX4, and upregulates GPX1, making cells more sensitive to ferroptosis. Combining GLS1 or GPX1 inhibitors with a GPX4 inhibitor synergistically suppresses cancer growth.
Changsen Bai+13 more
wiley +1 more source
Molecular characterization of a synthetic neutralizing antibody targeting p67 of Theileria parva. [PDF]
Miersch S+10 more
europepmc +1 more source
Application and future prospects of bispecific antibodies in the treatment of non-small cell lung cancer. [PDF]
Wen J+6 more
europepmc +1 more source
Immunogenetics in hematopathology and hematology: why a common language is important. [PDF]
Stamatopoulos K+3 more
europepmc +1 more source
Spontaneous Hepatic Hemorrhage as a Rare Presentation of Amyloid Light Chain (AL) Amyloidosis: A Case Report. [PDF]
Srivastava M.
europepmc +1 more source
Fc mutagenesis enhances the functionality of anti-RhD monoclonal antibodies. [PDF]
Heydarchi B+4 more
europepmc +1 more source
Using IMGT unique numbering for IG allotypes and Fc-engineered variants of effector properties and half-life of therapeutic antibodies. [PDF]
Lefranc MP, Lefranc G.
europepmc +1 more source